Nvidia among investors in xAI’s $20 bln capital raise- Bloomberg
Colgate Palmolive stock has reached a significant milestone, hitting a 52-week low at 78.69 USD, with InvestingPro data showing the company maintains a "GOOD" overall financial health score despite recent market pressures. This marks a notable decline for the consumer goods giant, reflecting a challenging year in which the stock has experienced a 21.34% decrease over the past 12 months. Yet, the company maintains impressive gross profit margins of 60.6% and has raised its dividend for 36 consecutive years, demonstrating fundamental strength. The drop to this new low suggests ongoing investor concerns and market pressures impacting the company’s performance. As Colgate Palmolive navigates these challenges, market observers will be keenly watching for any strategic moves or market shifts that could influence its stock trajectory in the coming months. InvestingPro analysis suggests the stock is currently undervalued, with 10+ additional exclusive insights available to subscribers through the comprehensive Pro Research Report.
In other recent news, Colgate-Palmolive Company announced a quarterly cash dividend of $0.52 per common share, continuing its 130-year streak of uninterrupted dividend payments. This dividend will be payable on November 14, 2025, to shareholders of record as of October 17, 2025. Morgan Stanley has adjusted its price target for Colgate-Palmolive to $96.00 from $104.00, while maintaining an Overweight rating, reflecting a mixed view on the stock. Meanwhile, Evercore ISI has reiterated its Outperform rating on Colgate-Palmolive, setting a price target of $100.00. The firm highlighted that Colgate’s strategy is proving effective, with the company achieving 2% organic sales growth against a challenging 9% comparison period. These developments come amid increased consumer and retail volatility in key global markets.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.